Brief

The medical devices regulations require manufacturers to inform users about corrective actions involving their device as soon as possible using a Field Safety Notice (FSN). Manufacturers must keep records to help trace distributed products and provide supplementary information to the MEDDEV guidelines. FSNs should be written in a clear style, avoiding jargon or technical language, and include crucial instructions for recipients. The MHRA reviews and monitors FSNS, with specialists conducting initial reviews and management meetings reviewing them selectively. Field corrective actions may arise from minor device-related safety issues, but are not considered FSCAs unless they pose a risk of death or serious injury.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies